Piperazines - Therapeutic use
Research News and Information

Sunday, November 22, 2009

Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).

13 Dec 2009 BACKGROUND: Allogeneic hematopoietic cell transplant (HCT) with best available donor for children with Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) has previously been considered standard practice. Since the introduction of ... Read more...

The treatment of pediatric Philadelphia positive (Ph+) leukemias in the imatinib era.

29 Nov 2009 BACKGROUND: As the treatment of Philadelphia positive (Ph+) leukemias in the era of imatinib continues to evolve, the role of allogeneic hematopoietic cell transplantation (allogeneic-HCT) in first remission is becoming more unclear. PROCEDURE: ... Read more...

Radiosensitization effect of STI-571 on pancreatic cancer cells in vitro.

30 Oct 2009 PURPOSE: To examine STI-571-induced radiosensitivity in human pancreatic cancer cells in vitro. METHODS AND MATERIALS: Three human pancreatic cancer cell lines (Bxpc-3, Capan-1, and MiaPaCa-2) exhibiting different expression levels of c-Kit and ... Read more...

Latest indexed articles for 'Piperazines - Therapeutic use'

These are the very latest articles for this heading:

• Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). 13 Dec 2009
• The treatment of pediatric Philadelphia positive (Ph+) leukemias in the imatinib era. 29 Nov 2009
• Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension. 3 Nov 2009
• Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression. 30 Oct 2009
• Radiosensitization effect of STI-571 on pancreatic cancer cells in vitro. 30 Oct 2009
• Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. 26 Oct 2009
• Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease. 20 Oct 2009
• Shifting paradigms: the seeds of oncogene addiction. 29 Sep 2009
• Attacking cancer at its foundation. 29 Sep 2009
• Perspectives on the development of imatinib and the future of cancer research. 29 Sep 2009
• Lasker Awards and papal portraiture: turning fields upside down. 29 Sep 2009
• Preserving fertility during cancer treatment. 29 Sep 2009
• Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole. 29 Sep 2009
• Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist. 29 Sep 2009
• Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13), PDGFRB-NDE1 fusion. 29 Sep 2009
• Attacking cancer at its root. 16 Sep 2009
• Association between widowhood and risk of diagnosis with a sexually transmitted infection in older adults. 15 Sep 2009
• The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. 6 Sep 2009
• Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way. 6 Sep 2009
• Prasugrel (Effient) vs. clopidogrel (Plavix). 5 Sep 2009

See a longer list of these articles.

Technical information about 'Piperazines'

Registry Number: 0

Descriptor UI: D010879

Alternative terms: Piperazines;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D03.383.606;